Olema Pharmaceuticals, Inc. - OLMA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | — | A | A | 29,500.0 | 0.0 | 0.0 | 29,500.0 | View | |
| Jun 23, 2026 | — | A | A | 29,500.0 | 0.0 | 0.0 | 29,500.0 | View | |
| Jun 23, 2026 | — | A | A | 29,500.0 | 0.0 | 0.0 | 29,500.0 | View | |
| Jun 23, 2026 | — | A | A | 29,500.0 | 0.0 | 0.0 | 29,500.0 | View | |
| Jun 23, 2026 | — | A | A | 29,500.0 | 0.0 | 0.0 | 29,500.0 | View | |
| Jun 23, 2026 | — | A | A | 29,500.0 | 0.0 | 0.0 | 29,500.0 | View | |
| Jun 23, 2026 | — | A | A | 29,500.0 | 0.0 | 0.0 | 29,500.0 | View | |
| Jun 23, 2026 | — | A | A | 29,500.0 | 0.0 | 0.0 | 29,500.0 | View | |
| Jun 23, 2026 | — | A | A | 29,500.0 | 0.0 | 0.0 | 29,500.0 | View | |
| Jun 23, 2026 | — | A | A | 29,500.0 | 0.0 | 0.0 | 29,500.0 | View | |
| Jun 23, 2026 | — | A | A | 29,500.0 | 0.0 | 0.0 | 29,500.0 | View | |
| Apr 29, 2026 | — | A | A | 24,150.0 | 0.0 | 0.0 | 24,150.0 | View | |
| Apr 29, 2026 | — | A | A | 2,911.0 | 0.0 | 0.0 | 2,911.0 | View | |
| Mar 05, 2026 | CHIEF LEGAL OFFICER | M | D | 25,000.0 | 0.0 | 0.0 | 410,000.0 | View | |
| Mar 05, 2026 | CHIEF LEGAL OFFICER | M | D | 15,000.0 | 0.0 | 0.0 | 435,000.0 | View | |
| Mar 05, 2026 | CHIEF LEGAL OFFICER | S | D | 233.0 | 24.69 | 5,752.77 | 0.0 | View | |
| Mar 05, 2026 | CHIEF LEGAL OFFICER | S | D | 24,767.0 | 24.25 | 600,599.75 | 233.0 | View | |
| Mar 05, 2026 | CHIEF LEGAL OFFICER | M | A | 25,000.0 | 4.37 | 109,250.0 | 25,000.0 | View | |
| Mar 05, 2026 | CHIEF LEGAL OFFICER | S | D | 15,000.0 | 23.01 | 345,150.0 | 0.0 | View | |
| Mar 05, 2026 | CHIEF LEGAL OFFICER | M | A | 15,000.0 | 4.37 | 65,550.0 | 15,000.0 | View | |
| Feb 17, 2026 | VP of Finance and Controller | A | A | 29,250.0 | 0.0 | 0.0 | 29,250.0 | View | |
| Feb 17, 2026 | VP of Finance and Controller | A | A | 11,700.0 | 0.0 | 0.0 | 16,188.0 | View | |
| Feb 04, 2026 | PRESIDENT AND CEO | A | A | 275,000.0 | 0.0 | 0.0 | 275,000.0 | View | |
| Feb 04, 2026 | PRESIDENT AND CEO | A | A | 850,000.0 | 0.0 | 0.0 | 850,000.0 | View | |
| Feb 04, 2026 | CHIEF LEGAL OFFICER | A | A | 56,250.0 | 0.0 | 0.0 | 56,250.0 | View | |
| Feb 04, 2026 | CHIEF LEGAL OFFICER | A | A | 220,000.0 | 0.0 | 0.0 | 220,000.0 | View | |
| Feb 04, 2026 | CH. DISCOV. & NON-CLIN DEV OFF | A | A | 106,250.0 | 0.0 | 0.0 | 106,250.0 | View | |
| Feb 04, 2026 | CH. DISCOV. & NON-CLIN DEV OFF | A | A | 250,000.0 | 0.0 | 0.0 | 250,000.0 | View | |
| Feb 04, 2026 | CHIEF MEDICAL OFFICER | A | A | 106,250.0 | 0.0 | 0.0 | 106,250.0 | View | |
| Feb 04, 2026 | CHIEF MEDICAL OFFICER | A | A | 250,000.0 | 0.0 | 0.0 | 250,000.0 | View |